\-\ Texto\\:\\ \ \(0\)\
\-\ \\â\\€\\¢\\ unremarkable\\ physical\\ exam\ \(0\)\
\-\ \\â\\€\\¢\\ laboratory\\ studies\\ within\\ normal\\ limits\ \(0\)\
\-\ \\â\\€\\¢\\ long\\-term\\ observation\\ with\\ interval\\ imaging\\ to\\ assess\\ for\\ progression\\ of\\ the\\ lesion\ \(0\)\
\-\ \\â\\€\\¢\\ medical\\ management\\ of\\ symptoms\\ \\(i\\.e\\.\\ pain\\ control\\)\ \(0\)\
\-\ \\â\\€\\¢\\ bisphosphonates\\ have\\ been\\ shown\\ to\\ reduce\\ bone\\ pain\ \(0\)\
\-\ \\â\\€\\¢\\ surgery\\ may\\ be\\ considered\\ for\\ complicated\\ lesions\\ with\\ mass\\ effect\\ and\\/or\\ resulting\\ fractures\ \(0\)\
\-\ ct\\ head\\ without\\ contrast\\:\\ expansile\\ ground\\ glass\\ lesion\\ involving\\ the\\ ethmoid\\ bone\\ and\\ crista\\ galli\\ with\\ extension\\ into\\ the\\ sphenoid\\ sinuses\\ with\\ mass\\ effect\\ on\\ the\\ medial\\ right\\ orbit\\ favored\\ to\\ represent\\ fibrous\\ dysplasia\\.\ \(0\)\
\-\ follow\\-up\\ ct\\ of\\ the\\ orbits\\ and\\ sinuses\\:\\ the\\ known\\ fibrous\\ dysplasia\\ is\\ again\\ seen\\ involving\\ the\\ crista\\ galli\\ and\\ ethmoid\\ bone\\ with\\ extension\\ into\\ the\\ sphenoid\\ sinuses\\.\\ minimal\\ interval\\ expansion\\ of\\ the\\ fibrous\\ dysplastic\\ lesion\\ of\\ the\\ ethmoid\\ bone\\ and\\ crista\\ galli\\ into\\ the\\ medial\\ right\\ orbit\\.\\ \ \(0\)\
\-\ bone\\ scan\\:\\ moderately\\ intense\\ tracer\\ activity\\ in\\ the\\ region\\ of\\ the\\ previously\\ described\\ ground\\-glass\\,\\ expansile\\ lesion\\ centered\\ on\\ the\\ ethmoid\\ air\\ cells\\,\\ involving\\ the\\ crista\\ galli\\ and\\ extending\\ into\\ the\\ sphenoid\\ sinuses\ \(0\)\
\-\ fibrous\\ dysplasia\ \(50\)\
\-\ \\â\\€\\¢\\ enchondroma\\ and\\ enchondromatosis\ \(0\)\
\-\ \\â\\€\\¢\\ eosinophilic\\ granuloma\\ \\(skeletal\\)\ \(0\)\
\-\ \\â\\€\\¢\\ fibrous\\ cortical\\ defect\\ and\\ nonossifying\\ fibroma\ \(0\)\
\-\ \\â\\€\\¢\\ giant\\ cell\\ tumor\ \(1\)\
\-\ \\â\\€\\¢\\ bone\\ hemangioma\ \(0\)\
\-\ \\â\\€\\¢\\ primary\\ hyperparathyroidism\ \(0\)\
\-\ \\â\\€\\¢\\ neurofibromatosis\\ type\\ i\ \(0\)\
\-\ \\â\\€\\¢\\ paget\\ disease\ \(0\)\
\-\ \\â\\€\\¢\\ metastases\ \(0\)\
\-\ 54\\ year\\ old\\ woman\\ with\\ headache\\ and\\ syncope\ \(1\)\
\-\ fibrous\\ dysplasia\\ is\\ a\\ skeletal\\ developmental\\ anomaly\\ of\\ the\\ bone\\-forming\\ mesenchyme\\ resulting\\ from\\ abnormal\\ osteoblast\\ function\\.\\ fibrous\\ dysplasia\\ is\\ a\\ nonheritable\\ disease\\ related\\ to\\ a\\ sporadic\\ mutation\\ in\\ the\\ gene\\ that\\ encodes\\ the\\ subunit\\ of\\ a\\ stimulatory\\ g\\ protein\\ on\\ chromosome\\ 20\\.\\ as\\ a\\ result\\,\\ osteoblasts\\ abnormally\\ produce\\ fibrous\\ tissue\\ within\\ the\\ bone\\ marrow\\.\\ fracture\\ is\\ the\\ most\\ common\\ complication\\ of\\ fibrous\\ dysplasia\\.\\ malignant\\ transformation\\ occurs\\ less\\ than\\ 0\\.5\\%\\ of\\ cases\\.\\ \ \(0\)\
\-\ fibrous\\ dysplasia\\ represents\\ approximately\\ 5\\%\\ of\\ all\\ benign\\ bone\\ tumors\\.\\ any\\ bone\\ can\\ be\\ affected\\.\\ 70\\%\\ of\\ cases\\ are\\ the\\ monostotic\\ form\\ whereas\\ 30\\%\\ are\\ of\\ the\\ polystotic\\ form\\.\\ the\\ incidence\\ rates\\ are\\ equal\\ in\\ males\\ and\\ females\\.\\ however\\ the\\ true\\ incidence\\ is\\ unknown\\ since\\ many\\ patients\\ are\\ asymptomatic\\.\\ \\ fibrous\\ dysplasia\\ usually\\ presents\\ in\\ persons\\ aged\\ 3\\-15\\.\\ most\\ cases\\ manifest\\ themselves\\ before\\ the\\ age\\ of\\ 30\\.\\ clinically\\ patients\\ present\\ with\\ pain\\ and\\ deformity\\ or\\ with\\ a\\ pathologic\\ fracture\\.\\ long\\ bones\\ are\\ commonly\\ affected\\.\\ the\\ femur\\ is\\ the\\ most\\ common\\ long\\ bone\\ affected\\.\\ other\\ common\\ areas\\ include\\ the\\ tibia\\,\\ facial\\ bones\\ and\\ skull\\.\\ \ \(0\)\
\-\ the\\ diagnosis\\ is\\ typically\\ made\\ with\\ plain\\ radiography\\.\\ characteristic\\ radiographic\\ findings\\ include\\ a\\ relatively\\ homogenous\\ lucent\\ lesion\\ with\\ or\\ without\\ bone\\ expansion\\ commonly\\ described\\ as\\ a\\ ground\\-glass\\ appearance\\.\\ additionally\\ the\\ lucent\\ lesion\\ has\\ a\\ thick\\ sclerotic\\ border\\ that\\ is\\ called\\ the\\ rind\\ sign\\.\\ there\\ should\\ be\\ an\\ absence\\ of\\ periosteal\\ reaction\\.\\ ct\\ is\\ commonly\\ used\\ to\\ assess\\ complex\\ areas\\ such\\ as\\ the\\ spine\\,\\ pelvis\\,\\ chest\\ and\\ craniofacial\\ bones\\.\\ ct\\ is\\ very\\ useful\\ in\\ evaluating\\ the\\ extent\\ of\\ disease\\ in\\ these\\ complex\\ areas\\.\\ nuclear\\ imaging\\ may\\ also\\ be\\ used\\ in\\ conjunction\\ with\\ other\\ imaging\\ modalities\\ to\\ assist\\ with\\ the\\ diagnosis\\ of\\ fibrous\\ dysplasia\\.\\ however\\ nuclear\\ imaging\\ is\\ not\\ specific\\ for\\ fibrous\\ dysplasia\\.\\ needle\\ biopsy\\ can\\ be\\ used\\ to\\ confirm\\ the\\ diagnosis\\ if\\ there\\ is\\ uncertainty\\.\ \(0\)\
\-\ asymptomatic\\ patients\\ do\\ not\\ require\\ treatment\\.\\ bisphosphonates\\ have\\ been\\ shown\\ to\\ be\\ helpful\\ treating\\ chronic\\ bone\\ pain\\ associated\\ with\\ fibrous\\ dysplasia\\.\\ surgical\\ treatment\\ is\\ indicated\\ for\\ the\\ treatment\\ and\\ prevention\\ of\\ pathologic\\ fractures\\.\\ surgery\\ may\\ also\\ be\\ utilized\\ for\\ the\\ treatment\\ of\\ severe\\ deformity\\.\ \(0\)\
\-\ references\\:\ \(0\)\
\-\ anand\\ mkn\\.\\ fibrous\\ dysplasia\\.\\<http\\:\\/\\/emedicine\\.medscape\\.com\\>\\ accessed\\ 01nov2009\\.\ \(0\)\
\-\ grossman\\ ri\\ and\\ yousem\\ dm\\.\\ neuroradiology\\:\\ the\\ requisites\\ 2nd\\ edition\\.\\ mosby\\ 2003\\.\\ \ \(0\)\
\-\ vargas\\ b\\,\\ and\\ clayer\\ m\\.\\ fibrous\\ dysplasia\\.\\ \\<http\\:\\/\\/imedicine\\.com\\>\\ accessed\\ 01nov2009\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ fibrous\\:\\ 0\\.4091530577556321\ \(0\)\
\-\ dysplasia\\:\\ 0\\.3277672959797565\ \(0\)\
\-\ the\\:\\ 0\\.2561774113341095\ \(0\)\
\-\ bone\\:\\ 0\\.2335054255372203\ \(0\)\
\-\ crista\\:\\ 0\\.2012227075352942\ \(0\)\
\-\ galli\\:\\ 0\\.2012227075352942\ \(0\)\
\-\ ethmoid\\:\\ 0\\.13770682802977563\ \(0\)\
\-\ sinuses\\:\\ 0\\.12402959460841104\ \(0\)\
\-\ of\\:\\ 0\\.12240215303581375\ \(0\)\
\-\ is\\:\\ 0\\.11719830349153265\ \(0\)\
\-\ and\\:\\ 0\\.10883889274830785\ \(0\)\
\-\ 01nov2009\\:\\ 0\\.10529119066238397\ \(0\)\
\-\ glass\\:\\ 0\\.09934335549658478\ \(0\)\
\-\ sphenoid\\:\\ 0\\.09934335549658478\ \(0\)\
\-\ ground\\:\\ 0\\.09613801289603906\ \(0\)\
\-\ lesion\\:\\ 0\\.09469431032316465\ \(0\)\
\-\ be\\:\\ 0\\.09347913891119403\ \(0\)\
\-\ bisphosphonates\\:\\ 0\\.08461088574117542\ \(0\)\
\-\ with\\:\\ 0\\.0837988814636903\ \(0\)\
\-\ affected\\:\\ 0\\.08122673308990398\ \(0\)\
\-\ bones\\:\\ 0\\.07946458488571008\ \(0\)\
\-\ accessed\\:\\ 0\\.07442643988274696\ \(0\)\
\-\ used\\:\\ 0\\.07393432885459975\ \(0\)\
\-\ commonly\\:\\ 0\\.0730767554192122\ \(0\)\
\-\ into\\:\\ 0\\.0699979550756196\ \(0\)\
\-\ imaging\\:\\ 0\\.06920144013836772\ \(0\)\
\-\ involving\\:\\ 0\\.06917493226426515\ \(0\)\
\-\ areas\\:\\ 0\\.067050361243128\ \(0\)\
\-\ cases\\:\\ 0\\.06642560310159958\ \(0\)\
\-\ to\\:\\ 0\\.0658386680727937\ \(0\)\
\-\ long\\:\\ 0\\.06548723888913437\ \(0\)\
\-\ lucent\\:\\ 0\\.06361434465631337\ \(0\)\
\-\ treatment\\:\\ 0\\.06272539507521407\ \(0\)\
\-\ are\\:\\ 0\\.06245744126277963\ \(0\)\
\-\ nuclear\\:\\ 0\\.062289617381238525\ \(0\)\
\-\ orbit\\:\\ 0\\.060976623937042555\ \(0\)\
\-\ assess\\:\\ 0\\.06085318000165198\ \(0\)\
\-\ expansion\\:\\ 0\\.060024174703991524\ \(0\)\
\-\ skeletal\\:\\ 0\\.05968633893891113\ \(0\)\
\-\ interval\\:\\ 0\\.05957588931197107\ \(0\)\
\-\ expansile\\:\\ 0\\.05957588931197107\ \(0\)\
\-\ form\\:\\ 0\\.057563520312602555\ \(0\)\
\-\ in\\:\\ 0\\.05732528399928398\ \(0\)\
\-\ incidence\\:\\ 0\\.056675243830695915\ \(0\)\
\-\ common\\:\\ 0\\.056007539090788545\ \(0\)\
\-\ patients\\:\\ 0\\.055557213783107684\ \(0\)\
\-\ resulting\\:\\ 0\\.05478664972194133\ \(0\)\
\-\ pathologic\\:\\ 0\\.053946868680862695\ \(0\)\
\-\ deformity\\:\\ 0\\.05381265905311726\ \(0\)\
\-\ described\\:\\ 0\\.05341914714555934\ \(0\)\
\-\ osteoblast\\:\\ 0\\.05264559533119199\ \(0\)\
\-\ nonheritable\\:\\ 0\\.05264559533119199\ \(0\)\
\-\ polystotic\\:\\ 0\\.05264559533119199\ \(0\)\
\-\ anand\\:\\ 0\\.05264559533119199\ \(0\)\
\-\ mkn\\:\\ 0\\.05264559533119199\ \(0\)\
\-\ vargas\\:\\ 0\\.05264559533119199\ \(0\)\
\-\ most\\:\\ 0\\.05139705866870057\ \(0\)\
\-\ diagnosis\\:\\ 0\\.05119585057625025\ \(0\)\
\-\ shown\\:\\ 0\\.0510387260262568\ \(0\)\
\-\ complex\\:\\ 0\\.05072816295091453\ \(0\)\
\-\ encodes\\:\\ 0\\.05030567688382355\ \(0\)\
\-\ stimulatory\\:\\ 0\\.05030567688382355\ \(0\)\
\-\ grossman\\:\\ 0\\.05030567688382355\ \(0\)\
\-\ yousem\\:\\ 0\\.05030567688382355\ \(0\)\
\-\ clayer\\:\\ 0\\.05030567688382355\ \(0\)\
\-\ ct\\:\\ 0\\.05013119205418805\ \(0\)\
\-\ for\\:\\ 0\\.04988837948851047\ \(0\)\
\-\ may\\:\\ 0\\.04969853119786306\ \(0\)\
\-\ fractures\\:\\ 0\\.048675009817460084\ \(0\)\
\-\ http\\:\\ 0\\.048675009817460084\ \(0\)\
\-\ mesenchyme\\:\\ 0\\.04864547832457407\ \(0\)\
\-\ uncertainty\\:\\ 0\\.04864547832457407\ \(0\)\
\-\ subunit\\:\\ 0\\.047357728277307026\ \(0\)\
\-\ osteoblasts\\:\\ 0\\.047357728277307026\ \(0\)\
\-\ pain\\:\\ 0\\.04711936699821519\ \(0\)\
\-\ extension\\:\\ 0\\.04660635124639959\ \(0\)\
\-\ persons\\:\\ 0\\.04630555987720563\ \(0\)\
\-\ ri\\:\\ 0\\.04630555987720563\ \(0\)\
\-\ effect\\:\\ 0\\.046185323485791574\ \(0\)\
\-\ craniofacial\\:\\ 0\\.04541596417047477\ \(0\)\
\-\ 30\\:\\ 0\\.044914268910089844\ \(0\)\
\-\ asymptomatic\\:\\ 0\\.04482205618574578\ \(0\)\
\-\ rind\\:\\ 0\\.044645361317956156\ \(0\)\
\-\ monostotic\\:\\ 0\\.043965641429837186\ \(0\)\
\-\ medial\\:\\ 0\\.04285631622296431\ \(0\)\
\-\ themselves\\:\\ 0\\.04230544287058771\ \(0\)\
\-\ chromosome\\:\\ 0\\.04184352048930931\ \(0\)\
\-\ disease\\:\\ 0\\.041455426604029046\ \(0\)\
\-\ neuroradiology\\:\\ 0\\.04141584716385685\ \(0\)\
\-\ favored\\:\\ 0\\.04101769282332067\ \(0\)\
\-\ enchondromatosis\\:\\ 0\\.04101769282332067\ \(0\)\
\-\ prevention\\:\\ 0\\.04029538271260564\ \(0\)\
\-\ as\\:\\ 0\\.03967490613999454\ \(0\)\
\-\ manifest\\:\\ 0\\.039357494264071195\ \(0\)\
\-\ assist\\:\\ 0\\.039357494264071195\ \(0\)\
\-\ include\\:\\ 0\\.03917371587161593\ \(0\)\
\-\ conjunction\\:\\ 0\\.03907592871648841\ \(0\)\
\-\ however\\:\\ 0\\.038969099912787554\ \(0\)\
\-\ syncope\\:\\ 0\\.03880746408024919\ \(0\)\
\-\ gene\\:\\ 0\\.03855093522689644\ \(0\)\
\-\ been\\:\\ 0\\.03835865511828408\ \(0\)\
\-\ nonossifying\\:\\ 0\\.038069744216804154\ \(0\)\
\-\ tracer\\:\\ 0\\.0378434034826914\ \(0\)\
\-\ fracture\\:\\ 0\\.03741867911908769\ \(0\)\
\-\ sporadic\\:\\ 0\\.03741573015723894\ \(0\)\
\-\ requisites\\:\\ 0\\.03741573015723894\ \(0\)\
\-\ orbits\\:\\ 0\\.03721321994137348\ \(0\)\
\-\ mutation\\:\\ 0\\.03701757581670275\ \(0\)\
\-\ utilized\\:\\ 0\\.03682834742250764\ \(0\)\
\-\ dm\\:\\ 0\\.03682834742250764\ \(0\)\
\-\ dysplastic\\:\\ 0\\.036645127304720325\ \(0\)\
\-\ treating\\:\\ 0\\.03612798010997189\ \(0\)\
\-\ aged\\:\\ 0\\.03596540741660136\ \(0\)\
\-\ surgery\\:\\ 0\\.03539793077815218\ \(0\)\
\-\ modalities\\:\\ 0\\.0352148774502972\ \(0\)\
\-\ whereas\\:\\ 0\\.03494001841011465\ \(0\)\
\-\ homogenous\\:\\ 0\\.03494001841011465\ \(0\)\
\-\ edition\\:\\ 0\\.03494001841011465\ \(0\)\
\-\ enchondroma\\:\\ 0\\.03480734707363128\ \(0\)\
\-\ without\\:\\ 0\\.034727694924442866\ \(0\)\
\-\ can\\:\\ 0\\.034550318688057295\ \(0\)\
\-\ or\\:\\ 0\\.03435642035653136\ \(0\)\
\-\ centered\\:\\ 0\\.03430520885735188\ \(0\)\
\-\ rates\\:\\ 0\\.03430520885735188\ \(0\)\
\-\ other\\:\\ 0\\.03419134601138313\ \(0\)\
\-\ mosby\\:\\ 0\\.03418621600313963\ \(0\)\
\-\ males\\:\\ 0\\.033955347258619276\ \(0\)\
\-\ transformation\\:\\ 0\\.03362548896923292\ \(0\)\
\-\ radiography\\:\\ 0\\.03362548896923292\ \(0\)\
\-\ reduce\\:\\ 0\\.03351959702636423\ \(0\)\
\-\ moderately\\:\\ 0\\.03321310293475556\ \(0\)\
\-\ fibroma\\:\\ 0\\.03311445183219493\ \(0\)\
\-\ females\\:\\ 0\\.03311445183219493\ \(0\)\
\-\ evaluating\\:\\ 0\\.03311445183219493\ \(0\)\
\-\ produce\\:\\ 0\\.03301745881008484\ \(0\)\
\-\ have\\:\\ 0\\.03289028448243664\ \(0\)\
\-\ abnormally\\:\\ 0\\.03273589326250205\ \(0\)\
\-\ neurofibromatosis\\:\\ 0\\.032645010298102406\ \(0\)\
\-\ paget\\:\\ 0\\.032645010298102406\ \(0\)\
\-\ eosinophilic\\:\\ 0\\.03204600429867969\ \(0\)\
\-\ true\\:\\ 0\\.03196529040998344\ \(0\)\
\-\ equal\\:\\ 0\\.03150336802870504\ \(0\)\
\-\ useful\\:\\ 0\\.03142985176103607\ \(0\)\
\-\ hyperparathyroidism\\:\\ 0\\.031357260250835364\ \(0\)\
\-\ thick\\:\\ 0\\.031285570521864474\ \(0\)\
\-\ complicated\\:\\ 0\\.031214760443679285\ \(0\)\
\-\ helpful\\:\\ 0\\.031214760443679285\ \(0\)\
\-\ intense\\:\\ 0\\.03107569470325258\ \(0\)\
\-\ 54\\:\\ 0\\.03100739865210276\ \(0\)\
\-\ also\\:\\ 0\\.030968865899551723\ \(0\)\
\-\ observation\\:\\ 0\\.03087318448738712\ \(0\)\
\-\ confirm\\:\\ 0\\.030807230067013358\ \(0\)\
\-\ called\\:\\ 0\\.03074202091027703\ \(0\)\
\-\ protein\\:\\ 0\\.03055070121366061\ \(0\)\
\-\ needle\\:\\ 0\\.03055070121366061\ \(0\)\
\-\ within\\:\\ 0\\.030323498543044204\ \(0\)\
\-\ progression\\:\\ 0\\.030186098996521717\ \(0\)\
\-\ anomaly\\:\\ 0\\.03012751017889439\ \(0\)\
\-\ extent\\:\\ 0\\.03012751017889439\ \(0\)\
\-\ 2nd\\:\\ 0\\.03012751017889439\ \(0\)\
\-\ complication\\:\\ 0\\.029898927864264655\ \(0\)\
\-\ on\\:\\ 0\\.029826846146502155\ \(0\)\
\-\ granuloma\\:\\ 0\\.029787944655985533\ \(0\)\
\-\ represents\\:\\ 0\\.029415496144003104\ \(0\)\
\-\ again\\:\\ 0\\.02936419848207518\ \(0\)\
\-\ giant\\:\\ 0\\.02936419848207518\ \(0\)\
\-\ border\\:\\ 0\\.02911433482557701\ \(0\)\
\-\ periosteal\\:\\ 0\\.02896944983592431\ \(0\)\
\-\ that\\:\\ 0\\.0285717373849704\ \(0\)\
\-\ developmental\\:\\ 0\\.028467311619644917\ \(0\)\
\-\ require\\:\\ 0\\.02829503169275189\ \(0\)\
\-\ control\\:\\ 0\\.02812774609673606\ \(0\)\
\-\ tibia\\:\\ 0\\.02812774609673606\ \(0\)\
\-\ reaction\\:\\ 0\\.028005389238366516\ \(0\)\
\-\ hemangioma\\:\\ 0\\.027691246439251936\ \(0\)\
\-\ sclerotic\\:\\ 0\\.02761531180463292\ \(0\)\
\-\ represent\\:\\ 0\\.027393324860970666\ \(0\)\
\-\ marrow\\:\\ 0\\.02735714324421745\ \(0\)\
\-\ clinically\\:\\ 0\\.02735714324421745\ \(0\)\
\-\ do\\:\\ 0\\.02728545351524656\ \(0\)\
\-\ 70\\:\\ 0\\.02717956157237788\ \(0\)\
\-\ facial\\:\\ 0\\.027144691684001347\ \(0\)\
\-\ additionally\\:\\ 0\\.02711003122564674\ \(0\)\
\-\ indicated\\:\\ 0\\.02707557769663466\ \(0\)\
\-\ femur\\:\\ 0\\.027007281645484844\ \(0\)\
\-\ relatively\\:\\ 0\\.026807113060395443\ \(0\)\
\-\ skull\\:\\ 0\\.02670957357277967\ \(0\)\
\-\ function\\:\\ 0\\.026645451257874944\ \(0\)\
\-\ metastases\\:\\ 0\\.026613655315356262\ \(0\)\
\-\ before\\:\\ 0\\.026613655315356262\ \(0\)\
\-\ characteristic\\:\\ 0\\.026613655315356262\ \(0\)\
\-\ previously\\:\\ 0\\.026426472994208076\ \(0\)\
\-\ absence\\:\\ 0\\.026245171728963276\ \(0\)\
\-\ references\\:\\ 0\\.026245171728963276\ \(0\)\
\-\ there\\:\\ 0\\.02619720753456404\ \(0\)\
\-\ limits\\:\\ 0\\.026011970345377843\ \(0\)\
\-\ not\\:\\ 0\\.025991744239862412\ \(0\)\
\-\ occurs\\:\\ 0\\.025955113245383445\ \(0\)\
\-\ many\\:\\ 0\\.025955113245383445\ \(0\)\
\-\ considered\\:\\ 0\\.02565203434961177\ \(0\)\
\-\ made\\:\\ 0\\.025389673308831438\ \(0\)\
\-\ cells\\:\\ 0\\.025364081475457264\ \(0\)\
\-\ mass\\:\\ 0\\.025148811224888795\ \(0\)\
\-\ minimal\\:\\ 0\\.025114217818959096\ \(0\)\
\-\ related\\:\\ 0\\.02501722479684901\ \(0\)\
\-\ unknown\\:\\ 0\\.02494553506787812\ \(0\)\
\-\ specific\\:\\ 0\\.02494553506787812\ \(0\)\
\-\ result\\:\\ 0\\.024644776284866582\ \(0\)\
\-\ radiographic\\:\\ 0\\.024423640074451008\ \(0\)\
\-\ management\\:\\ 0\\.024316170507469592\ \(0\)\
\-\ tumors\\:\\ 0\\.024210665759674253\ \(0\)\
\-\ activity\\:\\ 0\\.024168998077079895\ \(0\)\
\-\ studies\\:\\ 0\\.024148276514534918\ \(0\)\
\-\ defect\\:\\ 0\\.024148276514534918\ \(0\)\
\-\ laboratory\\:\\ 0\\.023905253281594832\ \(0\)\
\-\ since\\:\\ 0\\.023846063542535358\ \(0\)\
\-\ cortical\\:\\ 0\\.02363408499153787\ \(0\)\
\-\ very\\:\\ 0\\.023615194798015\ \(0\)\
\-\ malignant\\:\\ 0\\.023466258816722672\ \(0\)\
\-\ typically\\:\\ 0\\.023109914219028825\ \(0\)\
\-\ biopsy\\:\\ 0\\.023075460690016748\ \(0\)\
\-\ pelvis\\:\\ 0\\.023024163028088823\ \(0\)\
\-\ sign\\:\\ 0\\.022790624556362618\ \(0\)\
\-\ headache\\:\\ 0\\.022693359069061933\ \(0\)\
\-\ benign\\:\\ 0\\.022613538308738346\ \(0\)\
\-\ less\\:\\ 0\\.02239574080189778\ \(0\)\
\-\ extending\\:\\ 0\\.02231990595285233\ \(0\)\
\-\ type\\:\\ 0\\.02208372162708257\ \(0\)\
\-\ unremarkable\\:\\ 0\\.02206927619033249\ \(0\)\
\-\ right\\:\\ 0\\.02182841410638985\ \(0\)\
\-\ spine\\:\\ 0\\.02174663609947119\ \(0\)\
\-\ plain\\:\\ 0\\.021719414591599883\ \(0\)\
\-\ air\\:\\ 0\\.02153237672655174\ \(0\)\
\-\ should\\:\\ 0\\.021480032159352694\ \(0\)\
\-\ known\\:\\ 0\\.021313118774563957\ \(0\)\
\-\ any\\:\\ 0\\.021275276350646563\ \(0\)\
\-\ such\\:\\ 0\\.021175559848675807\ \(0\)\
\-\ approximately\\:\\ 0\\.021005097486274014\ \(0\)\
\-\ medical\\:\\ 0\\.020921718032186995\ \(0\)\
\-\ severe\\:\\ 0\\.020839526118391516\ \(0\)\
\-\ usually\\:\\ 0\\.020724103291492883\ \(0\)\
\-\ age\\:\\ 0\\.020667246191498484\ \(0\)\
\-\ primary\\:\\ 0\\.02024199814406803\ \(0\)\
\-\ appearance\\:\\ 0\\.019845946535917442\ \(0\)\
\-\ abnormal\\:\\ 0\\.019777650484767623\ \(0\)\
\-\ region\\:\\ 0\\.019691012426016105\ \(0\)\
\-\ head\\:\\ 0\\.019633967984919953\ \(0\)\
\-\ all\\:\\ 0\\.019596249229936514\ \(0\)\
\-\ chronic\\:\\ 0\\.019540129348768927\ \(0\)\
\-\ scan\\:\\ 0\\.01953082886493737\ \(0\)\
\-\ if\\:\\ 0\\.01912710142018397\ \(0\)\
\-\ lesions\\:\\ 0\\.018906095513322795\ \(0\)\
\-\ cell\\:\\ 0\\.018831523706542282\ \(0\)\
\-\ than\\:\\ 0\\.018661181152380305\ \(0\)\
\-\ these\\:\\ 0\\.01858968878491038\ \(0\)\
\-\ symptoms\\:\\ 0\\.018011736332142012\ \(0\)\
\-\ physical\\:\\ 0\\.017849758858097302\ \(0\)\
\-\ chest\\:\\ 0\\.017376629192736488\ \(0\)\
\-\ associated\\:\\ 0\\.01735109397864766\ \(0\)\
\-\ tissue\\:\\ 0\\.017268876328744524\ \(0\)\
\-\ tumor\\:\\ 0\\.01721885695629194\ \(0\)\
\-\ woman\\:\\ 0\\.017144631509025336\ \(0\)\
\-\ present\\:\\ 0\\.01689211220837221\ \(0\)\
\-\ exam\\:\\ 0\\.016571739426836474\ \(0\)\
\-\ findings\\:\\ 0\\.01624713940566668\ \(0\)\
\-\ surgical\\:\\ 0\\.015999995886196855\ \(0\)\
\-\ contrast\\:\\ 0\\.015994957955742968\ \(0\)\
\-\ presents\\:\\ 0\\.015836023326483876\ \(0\)\
\-\ seen\\:\\ 0\\.015498277696044394\ \(0\)\
\-\ has\\:\\ 0\\.015036710745368045\ \(0\)\
\-\ normal\\:\\ 0\\.013440848961360947\ \(0\)\
\-\ from\\:\\ 0\\.013074266571620216\ \(0\)\
\-\ an\\:\\ 0\\.01258834174326528\ \(0\)\
\-\ year\\:\\ 0\\.010145170336368702\ \(0\)\
\-\ old\\:\\ 0\\.009742875360777677\ \(0\)\
